Syneos health, inc. (SYNH)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Revenue

1,163,355

1,212,954

1,177,028

1,166,827

1,119,006

1,145,472

1,114,918

1,072,530

1,057,196

1,076,683

822,328

391,135

381,918

406,071

391,791

399,647

413,087

402,885

350,145

337,292

308,917

327,655

298,624

285,743

266,777

Costs and operating expenses:
Direct costs (exclusive of depreciation and amortization)

924,014

-

913,674

917,529

886,802

-

872,214

847,465

840,823

-

-

-

154,835

-

159,641

159,497

152,058

143,416

135,530

138,010

125,448

133,957

129,557

130,781

120,764

Selling, general, and administrative expenses

117,970

112,421

109,864

110,879

113,117

109,885

96,943

100,218

99,259

106,300

88,855

42,531

44,934

44,568

41,743

42,596

43,479

43,255

40,429

37,125

35,800

40,811

38,185

33,962

32,185

Restructuring and other costs

8,720

2,384

13,456

11,882

14,413

9,146

19,349

8,591

13,707

20,689

6,670

4,029

1,927

3,329

2,881

1,364

6,038

219

-28

2,012

-418

66

2,951

2,417

758

Transaction and integration-related expenses

7,577

26,509

10,454

7,654

16,658

3,037

18,561

18,032

25,211

15,734

84,340

23,739

2

286

1,127

1,169

561

715

403

397

122

5,860

0

0

2,042

Asset impairment charges

-

-

-

-

-

-

-

-

-

-

30,000

-

-

-

0

-

-

0

0

0

3,931

0

0

17,245

0

Depreciation

17,225

18,869

18,844

19,248

19,571

18,934

17,639

17,557

18,028

18,128

14,049

6,066

6,164

6,096

5,305

5,060

4,892

4,597

4,357

4,420

4,766

4,991

4,734

5,025

6,869

Amortization

38,882

41,510

41,293

41,501

41,629

51,194

50,395

49,945

49,993

65,220

51,383

9,462

9,464

9,463

9,464

9,463

9,461

9,461

9,462

9,473

9,478

9,587

9,597

6,238

7,502

Total operating expenses

1,114,388

1,129,593

1,107,585

1,108,693

1,092,190

1,066,004

1,075,101

1,041,808

1,047,021

1,061,663

911,216

380,885

347,166

362,271

352,395

359,992

380,579

363,192

305,804

301,353

276,530

309,202

275,885

277,871

252,197

Income from operations

48,967

83,361

69,443

58,134

26,816

79,468

39,817

30,722

10,175

15,020

-88,888

10,250

34,752

43,800

39,396

39,655

32,508

39,693

44,341

35,939

32,387

18,453

22,739

7,872

14,580

Other (income) expense, net:
Interest income

336

1,481

2,426

2,133

1,502

188

1,004

1,655

839

417

501

152

112

77

62

43

34

35

28

45

84

23

26

18

182

Interest expense

26,458

28,320

32,607

34,263

34,630

32,974

33,097

32,894

31,736

29,907

27,432

3,286

3,100

2,699

3,226

3,087

3,004

2,953

3,065

4,233

5,389

11,183

12,929

12,841

16,083

Loss on extinguishment of debt

0

14,750

0

0

-4,355

-239

-1,789

-1,877

-248

-520

-102

0

0

-

-439

-

-

-

0

-9,795

-

-

0

0

-

Other (income) expense, net

-18,930

-71,369

30,713

7,573

8,921

13,143

-4,346

32,001

-12,554

-3,682

-5,953

-6,754

-3,457

1,759

-2,384

-3,260

-5,117

-281

-1,003

1,675

3,466

1,512

5,136

-337

1,378

Total other expense, net

7,192

-158,424

532

-24,557

46,404

-19,882

-38,228

-1,115

-43,699

-33,692

-32,986

-9,888

-6,445

-863

-5,987

-6,304

-8,087

-3,199

-4,040

-12,308

-1,839

-56,398

-7,767

-13,160

-14,523

Income (loss) before provision for income taxes

41,800

17,709

70,000

33,600

-19,600

59,558

1,600

29,600

-33,500

-18,672

-121,874

362

28,307

42,937

33,409

33,351

24,421

36,494

40,301

23,631

30,548

-37,945

14,972

-5,288

57

Income tax expense

8,200

-73,349

11,100

22,300

10,400

13,974

12,000

16,000

-9,000

-3,625

26,124

-3,027

7,120

5,446

6,078

2,948

7,016

5,838

2,487

310

5,292

11,835

2,417

-20,595

1,609

Net income (loss)

33,574

91,050

58,920

11,292

-30,004

45,670

-10,394

13,560

-24,552

-15,047

-147,998

3,389

21,187

37,491

27,331

30,403

17,405

30,656

37,814

23,321

25,256

-49,780

12,555

15,307

-1,552

Class C common stock dividends

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

125

125

125

Net income (loss) attributable to common shareholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-53,155

12,430

15,182

-1,677

Earnings (loss) per share:
Basic (USD per share)

0.32

0.88

0.57

0.11

-0.29

0.44

-0.10

0.13

-0.24

-0.60

-1.70

0.06

0.39

0.70

0.50

0.56

0.32

0.54

0.67

0.40

0.41

-1.01

0.24

0.29

-0.03

Diluted (USD per share)

0.32

0.87

0.56

0.11

-0.29

0.44

-0.10

0.13

-0.24

-0.59

-1.70

0.06

0.38

0.69

0.49

0.54

0.31

0.52

0.64

0.39

0.40

-1.01

0.24

0.29

-0.03

Weighted average common shares outstanding:
Basic (in shares)

104,265

103,814

103,594

103,699

103,365

103,296

103,012

102,899

104,449

104,362

87,152

54,123

54,015

53,685

54,186

54,298

53,955

55,752

56,325

58,231

61,244

57,504

51,905

51,898

51,897

Diluted (in shares)

105,642

106,816

105,021

104,818

103,365

107,338

103,012

104,005

104,449

102,070

87,152

55,307

55,123

54,933

55,567

56,078

55,862

58,253

58,764

60,464

63,103

56,608

52,514

52,185

51,897

Revenue
Revenue

-

-

-

-

-

-

-

-

-

-

-

-

252,078

262,979

259,557

258,804

248,997

241,356

234,494

227,376

211,514

213,725

207,763

203,540

184,700

Reimbursable out-of-pocket expenses
Revenue

-

-

-

-

-

-

-

-

-

-

-

-

129,840

143,092

132,234

140,843

164,090

161,529

115,651

109,916

97,403

113,930

90,861

82,203

82,077